Submitted:
16 November 2026
Posted:
18 November 2026
You are already at the latest version
Abstract
Background/Objectives: Blood-count inflammatory indices may mark aggressive renal cell carcinoma (RCC), but their association with adverse pathology may reflect tumour size, anaemia or C-reactive protein (CRP). Methods: In a retrospective cohort of patients undergoing nephrectomy for RCC (2016–2025), five preoperative indices were related to pT3–4 stage and grade 3–4 in models fitted in the same patients, with adjustment for haemoglobin, tumour size (spline) and CRP, multiple imputation and assessment of incremental value. Results: Of 256 patients, 55/232 had pT3–4 and 71/235 grade 3–4 tumours. Per 1-SD increase in log systemic immune-inflammation index (SII), the odds ratio for pT3–4 was 2.21 (1.41–3.47) after adjustment for haemoglobin and size, 2.01 (1.07–3.76) with CRP added (137 patients) and 1.97 (1.27–3.05) after imputation. Adding SII to a model with tumour size increased the optimism-corrected AUC from 0.75 to 0.78. No leucocyte-based index was associated with grade after adjustment for haemoglobin. Conclusions: SII was associated with locally advanced RCC independently of tumour size, haemoglobin and CRP, but added little discrimination once tumour size was known. Validation against radiological staging is required.
Keywords:
renal cell carcinoma
; systemic immune-inflammation index
; neutrophil-to-lymphocyte ratio
; platelet-to-lymphocyte ratio
; red cell distribution width
; C-reactive protein
; tumour size
; pathological stage
; nuclear grade
; nephrectomy
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.